The effect of diclofenac on proliferation and production of growth factors by endothelial cells (HMEC-1) under hypoxia and inflammatory conditions

1. S. John, M. Schlaich, M. Langenfeld, H. Weihprecht, G. Schmitz, G. Weidinger and R. E. Schmieder, Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study, Circulation 98 (1998) 211-216; DOI: org/10.1161/01.CIR.98.3.211.Search in Google Scholar

2. C. Golias, A. Batistattou, G. Bablekos, A. Charalabopoulos, D. Peschos, P. Mitsopoulos and K. Charalabopoulos, Physiology and pathophysiology of selectins, integrins, and IgSF cell adhesion molecules focusing on inflammation. A paradigm model on infectious endocarditis, Cell. Commun. Adhes. 18 (2011) 19-32; DOI: org/10.3109/15419061.2011.606381.10.3109/15419061.2011.606381Search in Google Scholar

3. O. Ciftci, M. Caliskan, H. Gullu, D. Erdogan, S. Topcu, O. Guler, A. Yildirir and A. H. Muderrisoglu, Acute effects of smoking light cigarettes on coronary microvascular functions, Clin. Cardiol. 32 (2009) 210-214; DOI: org/10.1002/clc.20343.10.1002/clc.20343Search in Google Scholar

4. S. Kosaka, N. Pelisch, M. Rahman, D. Nakano, H. Hitomi, H. Kobori, N. Fukuoka, H. Kobara, H. Mori, T. Masaki, L. Cervenka, Y. Matsumura, H. Houchi and A. Nishivama, Effects of angiotensin II AT(1)-receptor blockade on high fat diet-induced vascular oxidative stress and endothelial dysfunction in Dahl salt-sensitive rats, J. Pharmacol. Sci. 121 (2013) 95-102.10.1254/jphs.12169FPSearch in Google Scholar

5. G. Y. Belgore, H. Lip and A. D. Blann, Basic fibroblast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells, Eur. J. Clin. Invest. 33 (2003) 833-839; DOI: 10.1046/j.1365-2362.2003.01223.x.10.1046/j.1365-2362.2003.01223.xSearch in Google Scholar

6. C. Muraki, N. Ohga, Y. Hida, H. Nishihara, Y. Kato, K. Tsuchiya, K. Matsuda, Y. Totsuka, M. Shindoh and K. Hida, Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells, Int. J. Cancer 130 (2012): 59-70; DOI: org/10.1002/ijc.25976.Search in Google Scholar

7. A. M. Olsen, E. L. Fosbøl, J. Lindhardsen, C. Andersson, F. Folke, M. B. Nielsen, L. Køber, P. R. Hansen, C. Torp-Pedersen, G. H. Gislason; Cause-specific cardiovascular risk associated with nonsteroidal anti-inflammatory drugs among myocardial infarction patients - a nationwide study, PLoS One 8 (2013):e54309; DOI: 10.1371/journal.pone.0054309.10.1371/journal.pone.0054309Search in Google Scholar

8. N. Bhala, J. Emberson, A. Merhi, S. Abramson, N. Arber, J. A. Baron, C. Bombardier, C. Cannon, M. E. Farkouh, G. A. FitzGerald, P. Goss, H. Halls, E. Hawk, C. Hawkey, C. Hennekens, M. Hochberg, L. E. Holland, P. M. Kearney, L. Laine, A. Lanas, P. Lance, A. Laupacis, J. Oates, C. Patrono, T. J. Schnitzer, S. Solomon, P. Tugwell, K. Wilson, J. Wittes and C. Baigent, Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials, Lancet 31 (2013) 769-779; DOI: 10.1016/ S0140-6736(13) 60900-9.Search in Google Scholar

9. H. C. Yao, T. Liu, X. Y. Meng, Q. F. Han, M. Zhang and L. X. Wang, Effect of basic fibroblast growth factor on the myocardial expression of hypoxia-inducible factor-1a and vascular endothelial growth factor following acute myocardial infarction, Heart Lung Circ. (in press); DOI: 10.1016/j.hlc.2013.04.111.10.1016/j.hlc.2013.04.111Search in Google Scholar

10. S. Wu, X. Wu, W. Zhu, W. J. Cai, J. Schaper and W. Schaper, Immunohistochemical study of the growth factors, aFGF, bFGF, PDGF-AB, VEGF-A and its receptor (Flk-1) during arteriogenesis, Mol. Cell. Biochem. 343 (2010) 223-229; DOI: 10.1007/s11010-010-0517-3.10.1007/s11010-010-0517-3Search in Google Scholar

11. J. A. Paramo, J. A. Rodriguez, O. Beloqui and J. Orbe, Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis? Current Drug Targets-Cardiovasc. Haemat. Dis. 5 (2005) 303-311; DOI: org/10.2174/1568006054553381.10.2174/1568006054553381Search in Google Scholar

12. A. Cucina, V. Borrelli, B. Randone, P. Coluccia, P. Sapienza and A. Cavallaro, Vascular endothelial growth factor increases the migration and proliferation of smooth muscle cells through the mediation of growth factors released by endothelial cells, J. Surg. Res. 109 (2003) 16-23; DOI: org/10.1016/S0022-4804(02)00042-2.10.1016/S0022-4804(02)00042-2Search in Google Scholar

13. S. Flis, D. Soltysiak-Pawluczuk, A. Jedrych, Z. Jastrzebski, M. Remiszewska and J. Splawinski, Antiangiogenic effect of sulindac sulfide could be secondary to induction of apoptosis and cell cycle arrest, Anticancer Res. 26 (2006) 3033-3042.Search in Google Scholar

14. Q. Chen, W. L. Liu, X. Guo, Y. J. Li and Z. G. Guo, Biphasic effect of aspirin on apoptosis of bovine vascular endothelial cells and its molecular mechanism, Acta Pharmacol. Sin. 28 (2007) 353-358; DOI: org/10.1111/j.1745-7254.2007.00518.x.10.1111/j.1745-7254.2007.00518.x17302997Search in Google Scholar

15. E. Niederburger, C. Manderscheid, S. Grosch, H. Schmidt, C. Ehnert and G. Geisslinger, Effects of selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells, Biochem. Pharmacol. 68 (2004) 341-350; DOI: org/10.1016/j.bcp.2004.03.029.10.1016/j.bcp.2004.03.029Search in Google Scholar

16. S. Boonmasawai, P. Akarasereenont, K. Techatraisak, A. Thaworn, S. Chotewuttakorn and T. Palo, Effects of selective COX-inhibitors and classical NSAIDs on endothelial cell proliferation and migration induced by human cholangiocarcinoma cell culture, J. Med. Assoc. Thai 92 (2009) 1508-1515.Search in Google Scholar

17. P. Akarasereenont, Y. S. Bakhle, C. Thiemermann and J. R. Vane, Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide, Br. J. Pharmacol. 115 (1995) 401-408; DOI: 10.1111/j.1476-5381.1995. tb16347.x.Search in Google Scholar

18. M. Namiecinska, A. Wiktorowska-Owczarek, A. Loboda, J. Dulak and J. Z. Nowak, Cyclic AMP generating system in human microvascular endothelium is highly responsive to adrenaline, Pharmacol. Rep. 58 (2006) 884-889.Search in Google Scholar

19. A. Loboda, A. Jazwa, B. Wegiel, A. Jozkowicz and J. Dulak, Heme oxygenase-1-dependent and -independent regulation of angiogenic expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells, Cell. Mol. Biol. 51 (2005) 347-355.Search in Google Scholar

20. A. Loboda, A. Jazwa, A. Jozkowicz, G. Molema and J. Dulak, Angiogenic transcriptome of human microvascular endothelial cells: effect of hypoxia, modulation by atorvastatin, Vascul. Pharmacol. 44 (2006) 206-214; DOI: org/10.1016/j.vph.2005.11.007.Search in Google Scholar

21. F. Grasselli, G. Basini, S. Bussolati and F. Bianco, Cobalt chloride, a hypoxia-mimicking agent, modulates redox status and functional parameters of cultured swine granulose cells, Reprod. Fer. Dev. 17 (2005) 715-720.10.1071/RD05059Search in Google Scholar

22. A. Wiktorowska-Owczarek, M. Józbwiak-Bezbenista and J. Z. Nowak, Effects of hypoxia on cyclic AMP signaling and VEGF/bFGF generation in different types of cultured cells, Pharmacol. Rep. 63 (2011) 574-575. 10.1016/S1734-1140(11)70545-XSearch in Google Scholar